ID

24686

Descripción

Study ID: 100478 Clinical Study ID: 100478 Study Title: Study to show non-inferiority of Tritanrix™-HepB/Hib-MenAC (+/- hepatitis B vaccine at birth) versus Tritanrix™-HepB/Hiberix™ without hepatitis B vacc. at birth for antibody response to all vaccine antigens given in healthy infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00290303 Sponsor: GlaxoSmithKline Phase: phase 3 Study Recruitment Status: Completed Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine Trade Name: Tritanrix HepB/Hiberix Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis This form contains the Non-Serious Adverse Events form

Palabras clave

Versiones (1)
  1. 13/8/17 13/8/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

13 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

Inglés

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

1 formularios  
Non-Serious Adverse Event
Descripción

Non-Serious Adverse Event

Alias
UMLS CUI-1
C1518404
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Descripción

non-serious adverse event

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1518404
AE No.
Descripción

AE No.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0877248
Description:
Descripción

Description

Tipo de datos

text

Alias
UMLS CUI [1]
C0678257
Administration Site
Descripción

Administration Site

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0013153
UMLS CUI [1,3]
C0042210
Non-administration site
Descripción

Non-administration site

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Date Started:
Descripción

Date Started:

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
during immediate postvaccination period (30 minutes)
Descripción

immediate postvaccination

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0231291
UMLS CUI [1,2]
C0877248
Date Stopped:
Descripción

Date Stopped:

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Maximum Intensity:
Descripción

Maximum Intensity:

Tipo de datos

integer

Alias
UMLS CUI [1]
C0518690
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Descripción

Relationship to investigational products:

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
Outcome:
Descripción

Outcome:

Tipo de datos

integer

Alias
UMLS CUI [1]
C1705586
Medically attended visit:
Descripción

(Refer to protocol for full definition.)

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0545082
Medically attended visit. If yes please specify type
Descripción

Refer to protocol for full definition.

Tipo de datos

integer

Alias
UMLS CUI [1]
C0545082
Volver a la parte superior de la página

Similar models

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Non-Serious Adverse Event
C1518404 (UMLS CUI-1)
non-serious adverse event
Item
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1518404 (UMLS CUI [1])
AE No.
Item
AE No.
integer
C0877248 (UMLS CUI [1])
Description
Item
Description:
text
C0678257 (UMLS CUI [1])
Administration Site
Item
Administration Site
boolean
C1515974 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Non-administration site
Item
Non-administration site
boolean
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Date Started:
Item
Date Started:
date
C0011008 (UMLS CUI [1])
immediate postvaccination
Item
during immediate postvaccination period (30 minutes)
boolean
C0231291 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Date Stopped:
Item
Date Stopped:
date
C0011008 (UMLS CUI [1])
Item
Maximum Intensity:
integer
C0518690 (UMLS CUI [1])
Maximum Intensity:
Code List
Maximum Intensity:
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Relationship to investigational products:
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0877248 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Item
Outcome:
integer
C1705586 (UMLS CUI [1])
Outcome:
Code List
Outcome:
CL Item
Recovered / resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae / resolved with sequelae (4)
Medically attended visit:
Item
Medically attended visit:
boolean
C0545082 (UMLS CUI [1])
Item
Medically attended visit. If yes please specify type
integer
C0545082 (UMLS CUI [1])
Medically attended visit:
Code List
Medically attended visit. If yes please specify type
CL Item
Hospitalisation (1)
CL Item
Emergency Room (2)
CL Item
Medical Personnel (3)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial